INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROME
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 321 (8320) , 313-315
- https://doi.org/10.1016/s0140-6736(83)91624-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Platelet Sensitivity to Prostacyclin and Prostaglandin E1 in Raynalid's SyndromeClinical Science, 1982
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982
- Effect of Cooling on Prostaglandin Mediated Inhibition of Platelet AggregationClinical Science, 1981
- Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's PhenomenonAnnals of Internal Medicine, 1981
- PROSTACYCLIN INCREASES CYCLIC-NUCLEOTIDE RESPONSIVENESS OF LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC SCLEROSISThe Lancet, 1980
- Hyperviscosity and Thrombotic Changes in Idiopathic and Secondary Raynaud's SyndromeBritish Journal of Haematology, 1980
- Raynaud's PhenomenonArchives of Surgery, 1979
- Raynaud's Disease: Reduced Hand Blood Flows with Normal Blood ViscosityAustralian and New Zealand Journal of Medicine, 1978
- Quantitative Thermographic Assessment of Inositol Nicotinate Therapy in Raynaud's PhenomenaJournal of International Medical Research, 1977
- THE TREATMENT OF PRIMARY RAYNAUD'S DISEASE OF THE UPPER LIMBThe Lancet, 1960